Exp Mol Med.  2017 Mar;49(3):e306. 10.1038/emm.2017.35.

Affibody molecules as engineered protein drugs

Affiliations
  • 1Affibody AB, Solna, Sweden. fredrik.frejd@affibody.com
  • 2Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • 3AbClon Inc., Guro-gu, Seoul, Republic of Korea.

Abstract

Affibody molecules can be used as tools for molecular recognition in diagnostic and therapeutic applications. There are several preclinical studies reported on diagnostic and therapeutic use of this molecular class of alternative scaffolds, and early clinical evidence is now beginning to accumulate that suggests the Affibody molecules to be efficacious and safe in man. The small size and ease of engineering make Affibody molecules suitable for use in multispecific constructs where AffiMabs is one such that offers the option to potentiate antibodies for use in complex disease.


MeSH Terms

Antibodies
Antibodies
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr